FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2109385800> ?p ?o ?g. }

• W2109385800 endingPage "442" @default.
• W2109385800 startingPage "435" @default.
• W2109385800 abstract "Sclerotic calcification of the aortic valve is a common disease in advanced age. Its pathophysiology is unclear. However, pathobiological similarities to atherosclerosis have been shown in several studies. The current study assesses gene profiling of severe calcified stenotic human aortic valves identifying transforming growth factor (TGF)-beta, Eotaxin3, vascular adhesion protein-1 (VAP-1) and monokine induced by interferon-gamma (MIG) as potential atherosclerotic target genes in severe calcified and stenotic aortic valves, and analyzes the effects of statins on their expression as part of an anti-inflammatory treatment strategy. We collected human severe calcified and stenotic aortic valves with (CSAV+) or without (CSAV-) statin pre-treatment prior to valve replacement and investigated gene profiling by using micro-array technique and real-time PCR for the TGF-beta, Eotaxin3, VAP-1 and MIG expression. In comparison to atherosclerotic plaques of carotid arteries, immunohistochemical staining was investigated. Results were contrasted to human normal non-calcified aortic valves as controls (C). As compared to C, TGF-beta, Eotaxin3, MIG or VAP-1 was significantly upregulated in CSAV-. In CSAV+ no significant change in gene expression was found for Eotaxin3 and MIG. In contrast, VAP-1 and TGF-beta were still upregulated. Corresponding gene expression was confirmed on atherosclerotic plaque formations of carotid arteries. Monocyte/Macrophage infiltration (presence of CD68) on aortic valves (CSAV+, CSAV-, or C) confirmed inflammatory nature of the disease. Our data support further evidence for atherosclerotic inflammation as a trigger for sclerosis in end-stage calcified stenotic aortic valves by showing upregulation of gene expression for TGF-beta, VAP-1, MIG and Eotaxin3, which is only partially inhibited by previous statin therapy. Potent benefits of statin treatment on early stages of valve disease are still propagated." @default.
• W2109385800 created "2016-06-24" @default.
• W2109385800 creator A5008306022 @default.
• W2109385800 creator A5019126088 @default.
• W2109385800 creator A5022164826 @default.
• W2109385800 creator A5032195705 @default.
• W2109385800 creator A5048584925 @default.
• W2109385800 creator A5061879992 @default.
• W2109385800 creator A5065530711 @default.
• W2109385800 creator A5071131587 @default.
• W2109385800 creator A5085217409 @default.
• W2109385800 creator A5091196503 @default.
• W2109385800 date "2007-12-01" @default.
• W2109385800 modified "2023-09-26" @default.
• W2109385800 title "VAP-1, Eotaxin3 and MIG as potential atherosclerotic triggers of severe calcified and stenotic human aortic valves: Effects of statins" @default.
• W2109385800 cites W1931636499 @default.
• W2109385800 cites W1975769445 @default.
• W2109385800 cites W1979235316 @default.
• W2109385800 cites W1984958865 @default.
• W2109385800 cites W2007320747 @default.
• W2109385800 cites W2007359045 @default.
• W2109385800 cites W2009992710 @default.
• W2109385800 cites W2020797302 @default.
• W2109385800 cites W2029583000 @default.
• W2109385800 cites W2057809694 @default.
• W2109385800 cites W2066963386 @default.
• W2109385800 cites W2069327346 @default.
• W2109385800 cites W2071238583 @default.
• W2109385800 cites W2075137754 @default.
• W2109385800 cites W2077744249 @default.
• W2109385800 cites W2082385280 @default.
• W2109385800 cites W2093452583 @default.
• W2109385800 cites W2096317541 @default.
• W2109385800 cites W2100748836 @default.
• W2109385800 cites W2101264497 @default.
• W2109385800 cites W2112098540 @default.
• W2109385800 cites W2117330772 @default.
• W2109385800 cites W2127536775 @default.
• W2109385800 cites W2131787811 @default.
• W2109385800 cites W2136376178 @default.
• W2109385800 cites W2138432239 @default.
• W2109385800 cites W2142021694 @default.
• W2109385800 cites W2152686325 @default.
• W2109385800 cites W2154006501 @default.
• W2109385800 cites W2157805334 @default.
• W2109385800 cites W2163408805 @default.
• W2109385800 cites W2168769447 @default.
• W2109385800 cites W54773614 @default.
• W2109385800 cites W2037943892 @default.
• W2109385800 doi "https://doi.org/10.1016/j.yexmp.2007.02.008" @default.
• W2109385800 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17490641" @default.
• W2109385800 hasPublicationYear "2007" @default.
• W2109385800 type Work @default.
• W2109385800 sameAs 2109385800 @default.
• W2109385800 citedByCount "28" @default.
• W2109385800 countsByYear W21093858002012 @default.
• W2109385800 countsByYear W21093858002013 @default.
• W2109385800 countsByYear W21093858002014 @default.
• W2109385800 countsByYear W21093858002015 @default.
• W2109385800 countsByYear W21093858002016 @default.
• W2109385800 countsByYear W21093858002017 @default.
• W2109385800 countsByYear W21093858002018 @default.
• W2109385800 countsByYear W21093858002019 @default.
• W2109385800 countsByYear W21093858002020 @default.
• W2109385800 countsByYear W21093858002021 @default.
• W2109385800 countsByYear W21093858002022 @default.
• W2109385800 crossrefType "journal-article" @default.
• W2109385800 hasAuthorship W2109385800A5008306022 @default.
• W2109385800 hasAuthorship W2109385800A5019126088 @default.
• W2109385800 hasAuthorship W2109385800A5022164826 @default.
• W2109385800 hasAuthorship W2109385800A5032195705 @default.
• W2109385800 hasAuthorship W2109385800A5048584925 @default.
• W2109385800 hasAuthorship W2109385800A5061879992 @default.
• W2109385800 hasAuthorship W2109385800A5065530711 @default.
• W2109385800 hasAuthorship W2109385800A5071131587 @default.
• W2109385800 hasAuthorship W2109385800A5085217409 @default.
• W2109385800 hasAuthorship W2109385800A5091196503 @default.
• W2109385800 hasConcept C126322002 @default.
• W2109385800 hasConcept C142724271 @default.
• W2109385800 hasConcept C164705383 @default.
• W2109385800 hasConcept C2776914184 @default.
• W2109385800 hasConcept C2780309369 @default.
• W2109385800 hasConcept C2780714102 @default.
• W2109385800 hasConcept C71924100 @default.
• W2109385800 hasConceptScore W2109385800C126322002 @default.
• W2109385800 hasConceptScore W2109385800C142724271 @default.
• W2109385800 hasConceptScore W2109385800C164705383 @default.
• W2109385800 hasConceptScore W2109385800C2776914184 @default.
• W2109385800 hasConceptScore W2109385800C2780309369 @default.
• W2109385800 hasConceptScore W2109385800C2780714102 @default.
• W2109385800 hasConceptScore W2109385800C71924100 @default.
• W2109385800 hasIssue "3" @default.
• W2109385800 hasLocation W21093858001 @default.
• W2109385800 hasLocation W21093858002 @default.
• W2109385800 hasOpenAccess W2109385800 @default.
• W2109385800 hasPrimaryLocation W21093858001 @default.
• W2109385800 hasRelatedWork W1532231795 @default.
• W2109385800 hasRelatedWork W1852171717 @default.

• next